Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pooled Analysis of Trabectedin Efficacy in Myxoid/Round Cell Liposarcoma from Three Prospective Clinical Trials.

Cancers·2026
Same author

LPAR4 mediates resistance to interferon-induced stress in soft tissue sarcoma.

Science advances·2026
Same author

Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

Cancer research communications·2026
Same author

Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States.

bioRxiv : the preprint server for biology·2026
Same author

Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

Nature medicine·2026
Same author

Drug Screening of Sarcoma Cells: Finding Shared Sensitivities.

Cancer research communications·2026

Related Experiment Video

Updated: Jun 25, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K

Mapping the Single-Cell Differentiation Landscape of Osteosarcoma.

Danh D Truong1, Corey Weistuch2, Kevin A Murgas3

  • 1Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|May 22, 2024
PubMed
Summary

Researchers mapped human mesenchymal stem cell differentiation to understand osteosarcoma heterogeneity. A stem-like transcriptomic phenotype correlated with poorer survival, offering therapeutic targets for osteosarcoma (OS) differentiation.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

6.9K

Related Experiment Videos

Last Updated: Jun 25, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

6.9K

Area of Science:

  • Biomedical research
  • Cancer biology
  • Stem cell biology

Background:

  • Genetic intratumoral heterogeneity in osteosarcoma complicates drug development and understanding of cell fate, plasticity, and differentiation.
  • These cellular processes are critical determinants of tumor grade, metastasis, and patient survival.

Purpose of the Study:

  • To identify and rectify errors in osteosarcoma (OS) differentiation pathways.
  • To establish a comprehensive atlas of human mesenchymal stem cell differentiation.
  • To correlate transcriptomic phenotypes with clinical outcomes in osteosarcoma.

Main Methods:

  • Transcriptional profiling of 31,527 cells from a tissue-engineered model directing mesenchymal stem cells (MSCs) toward adipogenic and osteoblastic fates.
  • Integration of existing chondrocyte data.
  • Application of trajectory analysis and non-negative matrix factorization (NMF) to create a human mesenchymal differentiation atlas.
  • Projection of bulk RNA-sequencing data from osteosarcoma tumors onto the differentiation atlas.

Main Results:

  • Generation of the first human mesenchymal differentiation atlas, serving as a reference for cellular composition and lineage commitment in osteosarcoma.
  • Quantification of cellular composition and lineage commitment within morphologically complex osteosarcoma tumors.
  • Discovery of a correlation between a stem-like transcriptomic phenotype and poorer survival outcomes in osteosarcoma patients.

Conclusions:

  • The study provides a quantitative measure of osteosarcoma differentiation and lineage commitment.
  • This detailed atlas is a prerequisite for understanding lineage-specific differentiation bottlenecks.
  • Identification of these bottlenecks may lead to future therapeutic strategies for osteosarcoma.